Business Context and Reporting Period
This Form 8-K was filed by Bioflamex Corporation (noted as Cann American Corp. in metadata) on May 14, 2012. The registrant is incorporated in Nevada with principal executive offices in Charlottenlund, Denmark. The filing reports the entry into a material definitive agreement regarding an equity financing facility.
Key Financial Metrics and Agreement Terms
The filing details an Investment Agreement with Dutchess Opportunity Fund, II, LP, establishing an equity line of credit rather than reporting standard operational financial metrics (revenue, profit, cash flow) for a specific period.
- Facility Size: Up to $10,000,000 in common stock purchases.
- Duration: 36 months from the first trading day following the effectiveness of the registration statement.
- Purchase Price: 95% of the lowest Volume Weighted Average Price (VWAP) during the five consecutive trading days beginning on the date of the draw-down notice.
- Draw Down Limit: Maximum of 5,000,000 shares per notice, calculated based on the prior day's VWAP.
- Ownership Cap: The Investor is not obligated to purchase shares if doing so would cause their beneficial ownership to exceed 4.99% of the Company's outstanding common stock.
- Registration Obligation: The Company must file a registration statement within 30 days to register the resale of initially 16,000,000 shares and use commercially reasonable efforts to have it declared effective within 90 days.
Material Changes
The primary material change is the establishment of the "Equity Line" financing facility. This agreement provides the Company with discretionary access to capital over a three-year period, subject to market conditions and regulatory effectiveness. No prior comparable period financial data is provided in this specific filing to assess changes in revenue or profitability.
Outlook, Risks, and Contingencies
Management Commentary and Outlook: The agreement allows the Company to draw on the facility at its discretion, providing flexibility for future capital needs. The Company retains the right to terminate the agreement at any time upon notice to the Investor.
Risks and Contingencies:
- Regulatory Risk: The ability to utilize the facility is contingent upon the effectiveness of a Registration Statement filed with the SEC.
- Market Risk: The purchase price is tied to the lowest VWAP over a five-day period, which may result in significant dilution if the stock price declines.
- Ownership Limitation: The 4.99% beneficial ownership cap may restrict the Company's ability to access the full $10,000,000 commitment if the Investor's holdings approach this threshold.
- Indemnification: Both parties are entitled to customary indemnification for losses resulting from breaches of the agreement or third-party lawsuits.
Investor Verification Checklist
- Verify the current status of the Registration Statement required to activate the equity line.
- Review the Company's current share count to assess the dilution impact of the 16,000,000 shares initially registered.
- Confirm the Investor's current beneficial ownership percentage to determine remaining capacity under the 4.99% cap.
- Examine the full text of the Investment Agreement (Exhibit 10.1) and Registration Rights Agreement (Exhibit 10.2) for specific covenants and termination clauses.
- Check subsequent filings to determine if any draw-downs have been executed under this facility.